Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : PRISM BioLab
Deal Size : Undisclosed
Deal Type : Collaboration
Elix and PRISM BioLab Collaborate to Accelerate AI-Driven Drug Discovery
Details : Elix's AI discovery platform will be integrated with PRISM PepMetics technology. The collaboration will expand the scope of AI-driven exploration to include previously unconsidered small molecules.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 15, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : PRISM BioLab
Deal Size : Undisclosed
Deal Type : Collaboration